Cullinan Therapeutics, Inc. (CGEM) insider trading

By person

7 insiders · 28 transactions

12.0×

Nadim Ahmed holds 12.0 times base salary in stock. $8.43M of shares against $698.48K in salary for 2025.

Salary from the company's own proxy. The shares are what Nadim Ahmed last reported holding, valued at $21.57, the price Common Stock was last bought or sold at on the open market here, on 8 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Jennifer Michaelson

Chief Scientific Officer

—

$1.62M (18) scheduled

−$1.62M

158,844

0.2468%

$3.43M

+44.5%

Nadim Ahmed

President and CEO

—

$517.99K (3)

−$517.99K

390,803

0.6073%

$8.43M

+43.9%

Jeffrey Alan Jones

Chief Medical Officer

—

$178.95K (3)

−$178.95K

159,968

0.2486%

$3.45M

+34.8%

Jacquelyn L Sumer

Chief Legal Officer

—

$136.72K (3)

−$136.72K

130,559

0.2029%

$2.82M

+35.8%

Mary Kay Fenton

Chief Financial Officer

—

$59.90K (1)

−$59.90K

127,921

0.1988%

$2.76M

+6,293%

Lynx1 Capital Management LP entity

10% owner

—

8,963,500

13.93%

$193.34M

+26.4%

Corrine Savill

Chief Business Officer

—

240,990

0.3745%

$5.20M

+18.4%

Cullinan Therapeutics, Inc.

What the insiders did Net selling

By person